27 results
8-K
EX-99.1
ELDN
Eledon Pharmaceuticals Inc
12 May 22
Eledon Pharmaceuticals Reports First Quarter 2022 Operating and Financial Results
12:00am
tegoprubart in kidney transplantation and islet cell transplantation with initial readouts anticipated in late 2022.
Hosted first-ever Company R&D Day
8-K
EX-99.1
wtpq7sc66t1q12v1v
15 Sep 20
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
5:19pm
8-K
EX-99.1
v5l3tz4
15 May 20
Novus Therapeutics Reports First Quarter 2020 Financial Results
6:32am
8-K
EX-99.1
j69wql8gxlenyv
17 Mar 20
Novus Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results
6:03am
PRE 14A
cl6qk4nlj66 gguqkamt
16 Mar 20
Preliminary proxy
12:00am
8-K
EX-99.1
5svuqk51rvy5jy0zmos
13 Nov 19
Novus Therapeutics Reports Third Quarter 2019 Financial Results
6:00am
8-K
EX-99.1
aj8buckri6m r13h7ad
13 Aug 19
Novus Therapeutics Reports Second Quarter 2019 Financial Results
4:37pm
8-K
EX-99.1
s6o bvojaps8vl9j60s0
14 May 19
Novus Therapeutics Reports First Quarter 2019 Financial Results
4:30pm
8-K
EX-99.1
8r73757ndz rz
28 Mar 19
Novus Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Clinical Updates
6:04am
8-K
EX-99.1
h41mavt1bsmj9me
13 Nov 18
Novus Therapeutics Reports Third Quarter 2018 Financial Results
7:58am